Given the implication of CD11b+ Gr-1+ MDSC in suppressing tumor immunosurveillance, angiogenesis and tumor invasion, it is possible that targeting the homing or function of MDSC becomes therapeutically effective. The gene discussed is ITGAM; the disease is neoplasm.